Skip to content

Clinical trials

Observational Prostatic Hyperplasia trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Hyperplasia Phase: Observational Country / region: France Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20121
20141
20171
20181
20202
20212
20221
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting2
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris2
University Hospital, Bordeaux2
Centre Hospitalier de Gonesse1
Clinique Saint-Hilaire1
Elsan1
GlaxoSmithKline1
Institute for Monitoring of Urogenital Diseases1
Merit Medical Systems, Inc.1
Pierre Fabre Medicament1
RECORDATI GROUP1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Hyperplasia14
Lower Urinary Tract Symptoms2
Prostatic Neoplasms2
Inflammation1
Multiple Endocrine Neoplasia Type 11

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.